Genetic and histologic studies of somatomammotropic pituitary tumors in patients with the 'complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas' (Carney complex)

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 10, 2000, Pages 3860-3865

  Pack, Svetlana D ^b,d   Kirschner, Lawrence S ^a   Pak, Evgenia ^b   Zhuang, Zhengping ^b,d   Carney, J Aidan ^c   Stratakis, Constantine A ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c MAYO CLINIC   (United States)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACROMEGALY; ADULT; ALBRIGHT SYNDROME; ARTICLE; CANCER INVASION; CARCINOGENESIS; CARNEY COMPLEX; CHROMOSOME LOSS; CHROMOSOME REARRANGEMENT; CLINICAL ARTICLE; FEMALE; GENETIC ANALYSIS; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASIA; HYPOPHYSIS TUMOR; MALE; MULTIPLE ENDOCRINE NEOPLASIA; PRIORITY JOURNAL;

EID: 0033767048     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.85.10.6875     Document Type: Article

References (43)

1. Primary pigmented nodular adrenocortical disease and its associated conditions
2. The familial lentiginosis syndromes are emerging from the obscurity imposed by rarity: New genes and genetic loci for multiple tumors and developmental defects
3. Carney complex: The complex of myxomas, spotty pigmentation, endocrine veractivity, and schwannomas
4. Carney complex: Diagnosis and management of the complex of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas
5. Dominant inheritance of the complex of myxomas, spotty pigmentation and endocrine overactivity
6. Carney complex, a familial multiple neoplasia and lentiginosis syndrome: Analysis of 11 kindreds and linkage to the short arm of chromosome 2
7. Identification of a novel genetic locus for familial cardiac myxomas and Carney complex
8. Genetic heterogeneity in Carney complex (OMIM 160980): Contributions of loci at chromosomes 2 and 17 in its genetic
9. Familial acromegaly beyond MEN-1: Genetic and clinical studies in non-GHRH dependent somatomammotroph hyperplasia in patients with Carney complex or an inherited chromosome 11 inversion
10. Prolactin abnormalities in patients with the syndrome of spotty skin pigmentation, myxomas, endocrine overactivity, and skin myxomas' (Carney complex)
11. The neurosurgical implications of Carney complex
12. Evidence for a second genetic locus in Carney complex
13. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome
14. Growth hormone-prolactinthyrotropin-secreting pituitary adenoma in atypical McCune-Albright syndrome with functionally normal Gsα protein
15. Acromegaly and hyperprolactinemia in a patient with polyostotic fibrous dysplasia: Dynamic endocrine studies and treatment with the somatostatin analogue octreotide
16. Hypersecretion of growth hormone and prolactin in McCune-Albright syndrome
17. Cytogenetic and microsatellite alterations in tumors from patients with the syndrome of myxomas, spotty skin pigmentation, and endocrine overactivity (Carney complex)
18. Sporadic cardiac myxomas and tumors from patients with Carney complex are not associated with activating mutations of the Gsα gene
19. Multiple endocrine neoplasia type 1: Clinical and genetic topics
20. Multiple endocrine neoplasia type 1 in patients with recognized pituitary tumours of different types
21. A concise genetic and clinical guide to multiple endocrine neoplasias and related syndromes
22. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors
23. Molecular cytogenetic finger-printing of esophageal squamous cell carcinoma by comparative genomic hybridization (CGH) reveals consistent pattern of chromosomal alterations
24. Comparative genomic hybridization: An overview
25. Comparative genomic hybridization (CGH) analysis of adrenocortical tumors in childhood
26. Current treatment guidelines for acromegaly
27. Criteria for cure of acromegaly: A consensus statement
28. Acromegaly with hyperprolactinemia developed after bilateral adrenalectomy in a patient with Cushing's syndrome due to adrenocortical nodular hyperplasia
29. The cytogenesis and pathogenesis of pituitary adenomas
30. Molecular genetics of pituitary tumors
31. Two different pituitary adenomas in a patient with multiple endocrine neoplasia type 1 associated with growth hormone-releasing hormone-producing pancreatic tumor: Clinical and genetic features
32. Thyroid gland abnormalities in patients with the 'syndrome of spotty skin pigmentation, myxomas, and endocrine overactivity'
33. Paradoxical response to dexamethasone in the diagnosis of primary pigmented nodular adrenocortical disease
34. Mammosomatotroph hyperplasia associated with acromegaly and hyperprolactinemia in a patient with the McCune-Albright syndrome
35. Growth hormone hypersecretion in a girl with McCune-Albright syndrome: Comparison with controls and response to a dose of long-acting somatostatin analog
36. Growth hormone-releasing hormone-producing tumors: Clinical, biochemical, and morphological manifestations
37. Somatotroph hyperplasia without pituitary adenoma associated with a long standing growth hormone-releasing hormone-producing bronchial carcinoid
38. Association of somatotrophinomas with loss of alleles on chromosome 11 and with gsp mutations
39. Comparative genomic hybridization studies in tumours from a patient with multiple endocrine neoplasia type 1
40. Genetic alterations in the adenoma-carcinoma sequence
41. The multistep nature of cancer
42. Hereditary cancer: Two hits revisited
43. YAC-BAC contig of the Carney complex (CNC) critical region on 2p16 and copy number gain of 2p16 in CNC tumors: Evidence for a novel oncogene?